Pellet formulation for the treatment of the intestinal tract

CAFC
  • US 6,551,620 B2
  • Filed: 07/16/2001
  • Issued: 04/22/2003
  • Est. Priority Date: 07/30/1997
  • Status: Expired due to Term
First Claim
Patent Images

1. An orally administrable pharmaceutical pellet formulation having a controlled release profile for the treatment of the intestinal tract, which comprises a core and an enteric coating and optionally pharmaceutically tolerable additives, the core including, as a pharmaceutical active compound, aminosalicylic acid or a pharmaceutically acceptable salt, wherein the active compound is present in the core in a non gel-forming polymer matrix which is essentially insoluble in the intestinal tract and permeable to intestinal fluids and the active compound, the matrix-forming polymer making up at least 1% by weight of the total weight of the core, and wherein the matrix-forming polymer is selected from the group consisting of poly(ethyl acrylate, methyl methacrylate) and poly(ethyl acrylate, methyl methacrylate, trimethylammonioethyl methacrylate chloride).

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×